149 related articles for article (PubMed ID: 37806170)
1. The updates on metastatic mechanism and treatment of colorectal cancer.
Ni Y; Liang Y; Li M; Lin Y; Zou X; Han F; Cao J; Li L
Pathol Res Pract; 2023 Nov; 251():154837. PubMed ID: 37806170
[TBL] [Abstract][Full Text] [Related]
2. Determinants of metastatic competency in colorectal cancer.
Tauriello DV; Calon A; Lonardo E; Batlle E
Mol Oncol; 2017 Jan; 11(1):97-119. PubMed ID: 28085225
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer: Metastases to a single organ.
Vatandoust S; Price TJ; Karapetis CS
World J Gastroenterol; 2015 Nov; 21(41):11767-76. PubMed ID: 26557001
[TBL] [Abstract][Full Text] [Related]
4. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
[TBL] [Abstract][Full Text] [Related]
5. Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse.
Al-Temaimi RA; Tan TZ; Marafie MJ; Thiery JP; Quirke P; Al-Mulla F
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136531
[TBL] [Abstract][Full Text] [Related]
6. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K
Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Zafari N; Velayati M; Nassiri M; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(28):2298-2311. PubMed ID: 35909286
[TBL] [Abstract][Full Text] [Related]
8. Metastatic recurrence in colorectal cancer arises from residual EMP1
Cañellas-Socias A; Cortina C; Hernando-Momblona X; Palomo-Ponce S; Mulholland EJ; Turon G; Mateo L; Conti S; Roman O; Sevillano M; Slebe F; Stork D; Caballé-Mestres A; Berenguer-Llergo A; Álvarez-Varela A; Fenderico N; Novellasdemunt L; Jiménez-Gracia L; Sipka T; Bardia L; Lorden P; Colombelli J; Heyn H; Trepat X; Tejpar S; Sancho E; Tauriello DVF; Leedham S; Attolini CS; Batlle E
Nature; 2022 Nov; 611(7936):603-613. PubMed ID: 36352230
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
10. Emerging mechanisms progress of colorectal cancer liver metastasis.
Zhao W; Dai S; Yue L; Xu F; Gu J; Dai X; Qian X
Front Endocrinol (Lausanne); 2022; 13():1081585. PubMed ID: 36568117
[TBL] [Abstract][Full Text] [Related]
11. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
Cells; 2021 May; 10(5):. PubMed ID: 34068719
[TBL] [Abstract][Full Text] [Related]
12. Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer.
Lee SY; Oh SC
Biomed Res Int; 2016; 2016():7590245. PubMed ID: 27127793
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary nodules and metastases in colorectal cancer.
Nordholm-Carstensen A
Dan Med J; 2016 Jan; 63(1):B5190. PubMed ID: 26726908
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
16. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract][Full Text] [Related]
17. The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis.
Yang L; Li T; Shi H; Zhou Z; Huang Z; Lei X
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):389-399. PubMed ID: 33174441
[No Abstract] [Full Text] [Related]
18. NFATc1 promotes epithelial-mesenchymal transition and facilitates colorectal cancer metastasis by targeting SNAI1.
Shen T; Yue C; Wang X; Wang Z; Wu Y; Zhao C; Chang P; Sun X; Wang W
Exp Cell Res; 2021 Nov; 408(1):112854. PubMed ID: 34597678
[TBL] [Abstract][Full Text] [Related]
19. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX
Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676
[No Abstract] [Full Text] [Related]
20. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
